sarepta therapeutics inc
(SRPT:Consolidated Issue Listed on NASDAQ Global Select )
Patrick L. Iversen Ph.D.
Former Senior Vice President of Research & Innovation, Sarepta Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 2 different industries.|
Dr. Patrick L. Iversen, Ph.D. has been Senior Vice President of Research and Innovation at AVI Biopharma, Inc. since October 2010. In this position, Dr. Iversen has expanded responsibility for the identification and advancement of new drug discovery initiatives and the development of novel therapeutic applications of AVI's RNA-based technology. Over the last 21 years, he has been a leading innovator in the research and development of RNA-based therapeutics. He served ...
215 First StreetPhone: 617-274-4000
Cambridge, Massachusetts 02142
Board Members Memberships*There is no Board Members Memberships data available.
The University of Utah
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Ron Cohen M.D.||Founder, Chief Executive Officer, President and Director|
Acorda Therapeutics, Inc.
|Edward M. Kaye M.D., Ph.D.||Interim Chief Executive Officer, Chief Medical Officer and Senior Vice President|
Sarepta Therapeutics, Inc.
|James A. Schoeneck||Chief Executive Officer, President and Director|
|Stephen R. Davis J.D.||Interim Chief Executive Officer, Chief Financial Officer, Chief Business Officer and Executive Vice President|
ACADIA Pharmaceuticals Inc.
|John M. Maraganore M.D., Ph.D.||Chief Executive Officer and Executive Director|
Alnylam Pharmaceuticals, Inc.
|$689.6K||Compensation as of Fiscal Year 2014.|